Back

Cardiovascular and metabolic comorbidities shape endothelial dysfunction in pulmonary arterial hypertension and may influence treatment: insights from a multicenter translational network

29 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Pulmonary hypertension: pathophysiology and mechanisms Pathophysiology and Mechanisms ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Rosalinda Madonna

University of Pisa, Pisa (Italy)

7 More presentations in this session

Presentation thumbnail
Plasma apelin levels in pulmonary arterial hypertension: a potential early diagnostic biomarker?
Doctor C. Tunca (Ankara, TR)
Abstract Slides Video
Presentation thumbnail
Exploratory study on the inhibitory effect of dihydrotanshinone on RNA-binding protein (HuR) in the treatment of pulmonary heart disease with right ventricular fibrosis
Professor X. Yu (Guangzhou, CN)
Abstract Slides Video
Presentation thumbnail
Multi-omics interrogation of energy metabolism reveals novel causal targets in pulmonary arterial hypertension
Mr S. Hou (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
CCR6⁺ T cells as potential drivers of inflammation in chronic thromboembolic pulmonary hypertension
Miss C. Ferreira (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Peripheral T-cell remodeling in long-standing PAH: CD4+ reduction and CCR6 enrichment
Miss C. Ferreira (Coimbra, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Pulmonary hypertension: pathophysiology and mechanisms

The Event

Event poster

ESC Congress 2026

29 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Ambrisentan reverses the prosenescent and anti-autophagic effect of high glucose on human pulmonary artery endothelial cells exposed to hypoxia
31 August 2024
thumbnail
Congress Presentation
Prognostic value of pulmonary hypertension in patients with advanced heart failure evaluated fort heart replacement therapy in the light of new definition of pulmonary hypertension.
27 August 2023
thumbnail
Congress Presentation
Evaluating the clinical importance of exercise-induced pulmonary hypertension and biomarker correlations in systemic sclerosis
28 August 2026
thumbnail
Congress Presentation
The importance of comorbidities in idiopathic and associated with connective tissue disease pulmonary arterial hypertension: from the Spanish Registry of Pulmonary Hypertension (REHAP Registry)
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources